SFX by Ex Libris Inc.

Title:	Targeting telomerase activity by BIBR1532 as a therapeutic approach in germ cell tumors
Source:	Investigational New Drugs [0167-6997] Mueller, Sandra yr:2007

Basic

Full text

Full text available via SpringerLINK Contemporary 1997-Present

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Brassat, U. "Characterization of Bcr-Abl positive leukemic cells under long-term in vitro treatment with telomerase inhibitor BIBR1532." Blood 2006. 620-.
description	2.	Wang, N. "Cytogenetic evidence for premeiotic transformation of human testicular cancers." Cancer research 41.6 (1981): 2135-40.
description	3.	Doi, T. "(S)-Stereoisomer of telomestatin as a potent G-quadruplex binder and telomerase inhibitor." Organic & biomolecular chemistry 9.2 (2011): 387-393.
description	4.	Gunaratnam, M. "Mechanism of acridine-based telomerase inhibition and telomere shortening." Biochemical Pharmacology 74.5 (2007): 679-689.
description	5.	Chakraborty, S. "Inhibition of telomerase activity and induction of apoptosis by curcurnin in K-562 cells." Mutation research 596.1-2 (2006): 81-90.
description	6.	Kim, M.-Y. Y. "Telomestatin, a potent telomerase inhibitor that interacts quite specifically with the human telomeric intramolecular G-quadruplex." Journal of the American Chemical Society 124.10 (2002): 2098-2099.
description	7.	Keppler, B. "BRACO19 analog dimers with improved inhibition of telomerase and hPot 1." Bioorganic & medicinal chemistry 17.5 (2009): 2030-2037.
description	8.	Nasir, L. A. "Inhibition of telomerase in canine cancer cells following telomestatin treatment." Veterinary and comparative oncology 5.2 (2007): 99-107.
description	9.	Mueller, T. "Failure of activation of caspase-9 induces a higher threshold for apoptosis and cisplatin resistance in testicular cancer." Cancer research 63.2 (2003): 513-21.
description	10.	Kauppinen, S. "LNA-modified oligonucleotides are highly efficient as FISH probes." Cytogenetic and genome research 107.1-2 (2004): 32-7.
description	11.	Darby, Richard A J J. "High throughput measurement of duplex, triplex and quadruplex melting curves using molecular beacons and a LightCycler." Nucleic acids research 30.9 (2002).
description	12.	Shin-ya, K. "Telomestatin, a novel telomerase inhibitor from Streptomyces anulatus." Journal of the American Chemical Society 123.6 (2001): 1262-1263.
description	13.	Prusty, Bhupesh K. "Constitutive activation of transcription factor AP-1 in cervical cancer and suppression of human papillomavirus (HPV) transcription and AP-1 activity in HeLa cells by curcumin." International journal of cancer 113.6 (2005): 951-960.
description	14.	Bermudez, Y. "Vitamin E suppresses telomerase activity in ovarian cancer cells." Cancer detection and prevention 31.2 (2007): 119-128.
description	15.	Yang, D. "Interaction between Human Telomere and a Carbazole Derivative: A Molecular Dynamics Simulation of a Quadruplex Stabilizer and Telomerase Inhibitor." The journal of physical chemistry. A 111.38 (2007): 9224-9232.
description	16.	Papandreou, I. "Cellular reaction to hypoxia: sensing and responding to an adverse environment." Mutation research 569.1-2 (2005): 87-100.
description	17.	White, Elizabeth W. "Structure-specific recognition of quadruplex DNA by organic cations: Influence of shape, substituents and charge." Biophysical chemistry 126.1-3 (2007): 140-153.
description	18.	Vissing, H. "FISHing with locked nucleic acids (LNA): evaluation of different LNA/DNA mixmers." Molecular and cellular probes 17.4 (2003): 165-9.
description	19.	Madden, K. "Proteomics-based approach to elucidate the mechanism of antitumor effect of curcumin in cervical cancer." Prostaglandins, leukotrienes, and essential fatty acids 80.1 (2009): 9-18.
description	20.	Bertolaso, L. "Apoptosis in the OC-k3 immortalized cell line treated with different agents." Audiology 40.6 (2001): 327-35.